Student Profiles

Background Header

1 Search Results

Kritika Singh

Kritika Singh

Scholar Type:

NIH Rhodes Scholar

Entry Year: 2020

B.S. Bioengineering,
Northeastern University, 2020


Dr. John Schiller (NCI), Prof. Eleanor Stride (Oxford),
Prof. Udo Oppermann (Oxford), and Dr. Ralph Mazitschek (Harvard)

Research Interest:

Chemical biology, Bioengineering, Immuno-oncology

Kritika’s passion for biomedical research started in high school during an internship at Acetylon Pharmaceuticals where she worked on epigenetics and malaria. This drove Kritika to pursue additional research experiences at the Wirth Lab at Harvard TH Chan School of Public Health and the Long Lab at the NIAID. Her research experiences in high school also inspired her to found a non-profit, Malaria Free World, which engages in national and international peer-to-peer education on infectious diseases.
In 2020, Kritika graduated summa cum laude from Northeastern University BS in Bioengineering and a minor in chemistry. She attended Northeastern as a University Scholar, member of the Honors Department, and a Presidential Scholar. She furthered her passional for translational research and spent 4 years in the lab of Ralph Mazitschek at Massachusetts General Hospital working on malaria, epigenetics, and platform development. Throughout undergrad, she also developed her passion for connecting the bench and the bedside by shadowing physician-scientist, Dr. Ken Anderson at the Dana Farber Cancer Institute. At Northeastern, she founded the Northeastern University Global Health Initiative (NUGHI) which organizes and develops novel content for an annual, international and interdisciplinary student-led global health conference while connecting students, faculty, and experts.
A recipient of the Rhodes, Truman, and Goldwater Scholarships, Kritika understands that science alone will not eradicate disease. She aims to integrate biomedical research, clinical practice, and global health policy in her career and is excited to pursue her PhD at the intersection of bioengineering, chemical biology, and immuno-oncology. Her goal is to develop technologies and therapies that can be widely adapted in high- and low-resource settings.

Back to Top